E-viri
Recenzirano
Odprti dostop
-
Engelberg, Isabelle A.; Foley, Caroline A.; James, Lindsey I.; Frye, Stephen V.
Current opinion in chemical biology, 08/2021, Letnik: 63Journal Article
Responsible for interpreting histone post-translational modifications, epigenetic reader proteins have emerged as novel therapeutic targets for a wide range of diseases. Chemical probes have been critical in enabling target validation studies and have led to translational advances in cancer and inflammation-related pathologies. Here, we present the most recently reported probes of reader proteins that recognize acylated and methylated lysine. We will discuss challenges associated with achieving potent antagonism of reader domains and review ongoing efforts to overcome these hurdles, focusing on targeting strategies including the use of peptidomimetic ligands, allosteric modulators, and protein degraders.
